MedTrace Logo

Brachytherapy Innovations in Gynecologic Cancer

NCT04530019 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-11-29

No results posted yet for this study

Summary

In this pilot study, the investigators will test tools designed to more precisely identify, define and create a radiation treatment plan to tumor remnants as separate from fibrotic or normal tissue in a Magnetic Resonance (MR) simulator in the department of radiation oncology. The investigators will examine if this beneficial for tumor versus normal tissue delineation, will result in more precise tumor targeting with radiation in an efficient manner and whether there would be fewer toxicities.

Conditions

  • Gynecologic Cancer

Sponsors & Collaborators

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    lead OTHER

Principal Investigators

  • Akila Viswanathan, MD · Johns Hopkins, School of Medicine, Radiation Oncology

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2030-12-31
Completion
2032-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04530019 on ClinicalTrials.gov